Lista de obras - Richard Milne - Dominio Público Uruguay

Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease.

artículo científico publicado en 2018

At, with and beyond risk: expectations of living with the possibility of future dementia.

artículo científico publicado en 2018

Attitudes of publics who are unwilling to donate DNA data for research.

artículo científico publicado en 2018

Ethical Challenges Associated with Pathogen and Host Genetics in Infectious Disease

artículo científico publicado en 2022

Expanding engagement with the ethical implications of changing definitions of Alzheimer's disease.

artículo científico publicado en 2017

GA4GH: International policies and standards for data sharing across genomic research and healthcare

artículo científico publicado en 2021

Members of the public in the USA, UK, Canada and Australia expressing genetic exceptionalism say they are more willing to donate genomic data

artículo científico publicado en 2019

On the personal utility of Alzheimer's disease-related biomarker testing in the research context

artículo científico publicado en 2018

Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.

artículo científico publicado en 2018

Pharmaceutical prospects: biopharming and the geography of technological expectations.

artículo científico publicado en 2012

Professional duties are now considered legal duties of care within genomic medicine

artículo científico publicado en 2020

Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.

artículo científico publicado en 2016

Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes

scientific article published on 01 November 2018

Should doctors have a legal duty to warn relatives of their genetic risks?

scientific article published on 26 November 2019

Societal considerations in host genome testing for COVID-19

artículo científico publicado en 2020

Strategies to improve recruitment of people with dementia to research studies.

artículo científico publicado en 2018

The rare and the common: scale and the genetic imaginary in Alzheimer's disease drug development

scientific article published on 16 July 2019

Trust in genomic data sharing among members of the general public in the UK, USA, Canada and Australia

artículo científico publicado en 2019

We need to think about data governance for dementia research in a digital era

scientific article published on 31 January 2020

Lista de obras de Richard Milne

Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease.

At, with and beyond risk: expectations of living with the possibility of future dementia.

Attitudes of publics who are unwilling to donate DNA data for research.

Ethical Challenges Associated with Pathogen and Host Genetics in Infectious Disease

Expanding engagement with the ethical implications of changing definitions of Alzheimer's disease.

GA4GH: International policies and standards for data sharing across genomic research and healthcare

Members of the public in the USA, UK, Canada and Australia expressing genetic exceptionalism say they are more willing to donate genomic data

On the personal utility of Alzheimer's disease-related biomarker testing in the research context

Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.

Pharmaceutical prospects: biopharming and the geography of technological expectations.

Professional duties are now considered legal duties of care within genomic medicine

Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.

Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes

Should doctors have a legal duty to warn relatives of their genetic risks?

Societal considerations in host genome testing for COVID-19

Strategies to improve recruitment of people with dementia to research studies.

The rare and the common: scale and the genetic imaginary in Alzheimer's disease drug development

Trust in genomic data sharing among members of the general public in the UK, USA, Canada and Australia

We need to think about data governance for dementia research in a digital era